Annovis Announces New Publication in a Peer-Reviewed Journal
MALVERN, Pa., May 21, 2024 -- Annovis Bio, Inc. , a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, announced the publication of a new article...
Source: marketscreener.com